patient factors and health system factors. Similar to other chronic non-communicable diseases (NCDs), such as diabetes and hypertension, there are many barriers to timely treatment of breast cancer.
Several studies have been conducted on various aspects of breast cancer in Ghana, including patient delay that explores the causes of delay in seeking initial treatment (Atobrah, 2013) . But there is presently no study which examines patients' perspectives on the causes of delay in start of treatment between first presentation at the hospital for diagnosis with breast cancer and the start of definitive treatment. As part of a large-scale hospital-based study of patients who have started treatment for breast cancer at the Korle-Bu Teaching Hospital (KBTH), Accra, this study explored the patients', healthcare providers' and health systems' factors which accounted for delay in start of definitive treatment, using a qualitative approach. In this study, delay was defined as the time interval (and factors responsible for that interval) between presentation to hospital and start of definitive treatment for breast cancer.
Methods
Data were gathered using focus group discussions (FGDs) to examine the structure, process and outcomes of social communication in order to gain insight into 'how knowledge, and more importantly ideas, develop and operate within a given cultural context' (Kitzinger, 1995) . Four FGDs were carried out with patients receiving treatment from the general surgical wards and outpatient clinics of the department of surgery, and the breast clinic of the National Centre for Radiotherapy and Nuclear Medicine, KBTH.
Participants
Participants were recruited using purposive sampling from the general surgical wards, outpatient clinics and the breast clinic of the National Centre for Radiotherapy and Nuclear Medicine at KBTH. The fieldwork was carried out between August and September 2013. The first phase of the fieldwork was a survey where 205 consecutive breast cancer patients starting treatment at the study sites were recruited (Dedey et al., 2016) . After the survey, we followed up some of the patients by calling them on their mobile phones to request their participation in an FGD to gather more nuances and in-depth information on the causes of delay in start of definitive treatment. We were able to approach 31 patients at this stage and 11 of them declined. Once participants had agreed, we set up their interview dates and they were placed in groups based on their clinic days. The FGDs were conducted in English and Twi by trained field assistants. The duration of the group discussions ranged from 1 hour, 30 minutes to 2 hours, 30 minutes and permission was sought from the participants to record all discussions. Ethical approval for the study was obtained from the Ethical and Protocol Review Committee of University of Ghana Medical School.
Furthermore, all participants were remunerated for participating in the study. Each participant was given GH20 (US$9.67) as transport allowance. Two pre-defined key areas were explored in this study: (1) general life history and (2) patients, healthcare providers' and health systems' causes of delay in start of breast cancer treatment. Questions asked during the FGDs are provided in Supplemental Box 1.
The profiles of the breast cancer patients are presented in Table 1 and Supplemental  Table 1b .
Data analysis
The data analysis was conducted after all the interviews were transcribed. All interviews were transcribed verbatim from Twi to English language by a team of transcribers with Twi and English language competence. We analysed the data using thematic approach (Attride-Stirling, 2001 ). The analysis was guided by a coding frame with two sections: (1) a section on preexisting deductive codes derived from previous studies on causes of delay in breast cancer treatment and (2) an open-ended section of inductive codes derived from the lived experience of the participants. The study by Freitas and Weller (2015) on 'patient delays and systems delays in breast cancer treatment in developed and developing countries' and the review of breast cancer research in Ghana by Atobrah (2013) guided the selection of the deductive codes. Deductive codes derived from the reference studies included financial constraints; non-attribution of symptoms to cancer; and fear of disease, treatment adverse effect and chemotherapy. Deductive codes for healthcare provider and health system factors were derived from key elements of the World Health Organization (WHO) health systems' building blocks (service delivery, health workforce, information system, medicines, financing and leadership/ governance; Coast et al., 2016) and the application of this framework to cancer care in Africa (Adeloye and Grant, 2016) . Using the principle of constant comparison, the emerging themes were compared against each other to describe the depth and coverage of themes across transcripts. We paid critical attention to consensus, conflict and absences across group and individual narratives (de-Graft Aikins, 2005) .
The second stage of the analytical framework involved drawing linkages between codes, themes, appropriate respondent quotes, existing empirical studies and conceptual ideas from social representation theory (de-Graft Aikins, 2005) and explanatory models of illness (Kleinman, 1980) . The concepts of social representation and explanatory models shaped the interpretive analysis because we were interested in the sources of knowledge and how sources influenced practical responses on treatment. At the interpretive stage, we recategorised some of the themes mentioned by participants, partly informed by convergent and divergent themes from existing studies. For instance, participants reported different dimensions of fear; we highlighted the different levels through which fear operated so that we could identify the extent to which this theme aligned with existing studies that had reported fear as a barrier to start of definitive treatment.
Results
The results focus on causes of delay in breast cancer treatment.
Causes of delay in breast cancer treatment
Causes of delay in breast cancer treatment are presented under three broad categories: (1) patient factors, (2) healthcare provider factors and (3) health system factors. All the categories were examined from the patients' perspectives.
Patient factors
The participants attributed their causes of delay in start of definitive treatment to four main themes: (1) spiritual causal theories of breast cancer, (2) fear, (3) financial constraints and (4) seeking alternative treatment.
Spiritual causal theories of breast cancer.
A major cause of delay in start of definitive treatment was spiritual causal theories of breast cancer. Participants attributed the causes of breast cancer to spiritual causes such as witchcraft, breastfeeding in dreams and consequence of one's sin. These theories influenced their decision to seek spiritual help before starting biomedical treatment: Fear was also driven by the perceptions of women's significant others. There was a common perception that mastectomy damaged 'female identity' or 'ideal womanhood'. Women were advised against the procedure, as a result. These perceptions intensified the fear women felt about cancer and prevented them from seeking definitive treatment: 
Healthcare provider factors
Participants mentioned that healthcare providers also contributed to the delay in start of definitive treatment. The healthcare provider factors which accounted for delay in start of definitive treatment included the following: (1) the healthcare workers' attitude, (2) corruption among the healthcare workers and (3) wrong/ harmful advice from healthcare workers. The dominant healthcare provider factor mentioned and discussed by the majority of the participants was poor attitude of the health workers. Patients stated that some of the healthcare workers were rude to them or refused to answer their questions and did not treat them well and this forced them to delay start of treatment or stopped treatment for some time. In addition, participants mentioned that some of the health workers are corrupt because they give preferential treatment to patients who they know: 
Health system factors
The health system factors that led to delay in treatment, as narrated by the participants, include the following: (1) long queues during treatment, (2) unavailability of doctors, (3) breakdown of hospital machines, (4) shortage of medicines, (5) workload of doctors, (6) shortage of healthcare workers, (7) slow moving queues at the drug dispensary and (8) long distance between departments involved in breast cancer treatment within the hospital premises. Some of the participants mentioned that the structure of breast cancer treatment at KBTH contributed to the delay. Treatment facilities were located at different places within the hospital premises, and this made it strenuous for patients to access these facilities. The dominant theme for the health system's delay, mentioned and discussed by many of the participants, was delay of biopsy results from the Pathology Department: 
Recommendations on how to reduce delay in start of treatment
The recommendations on how to reduce delay in start of treatment at KBTH are based on the narratives of the participants. The participants were asked to suggest ways to reduce delay in start of breast cancer treatment. The narratives of the participants were thematised based on the WHO health systems' building blocks and these focused on the following: (1) health service delivery, (2) health workforce and (3) financing. We present these themes in Supplemental Table 2 , highlighting the spread of views across groups.
Discussion
This discussion focuses on the three factors driving delay in start of breast cancer treatment: patients, health professionals and health systems.
Patient factors
The dominant patient factor for causes of delay in start of breast cancer treatment among the participants was fear. Fear has also been identified in several studies as one of the most dominant causes of delay in start of breast cancer treatment in high-income countries, and lowand middle-income countries (LMICs; Crowley et al., 2014; Freitas and Weller, 2015; Innos et al., 2013) . Fear operated at multiple levels of analysis: the level of self (changed body), the level of intimate and socially significant relationships (changed identity as a woman), the level of macro-structure (fear of KBTH) and the level of the supernatural (fear of the spiritual causes of cancer). There is a need to identify the multi-faceted (subjective, material and symbolic) targets of women's fear in order to develop appropriate psychosocial counselling and support.
Another major cause of participants' delay in start of treatment was financial constraints. Financial constraints as a cause of patient delay have also been cited in other studies (Atobrah, 2013; Barros et al., 2013; Dedey et al., 2016; Ermiah et al., 2012; Quaife et al., 2014; Sharma et al., 2013) . High cost of biomedical treatment forced some of the participants to seek alternative sources of healing which resulted in delay in start of treatment. The economic downturn in Ghana, coupled with high cost of living, makes it difficult for most families to meet their dayto-day needs; chronic illnesses such as breast cancer often introduce catastrophic healthcare expenditures within this context (de-Graft Aikins et al., 2014; Tagoe, 2012) . Participants struggled to pay their cancer care costs. Those who had health insurance, still had to pay outof-pocket at the point of healthcare delivery because many of the breast cancer treatments were not covered by the National Health Insurance Scheme (NHIS). Experts observe that NCDs send patients and their families down a poverty spiral, particularly in LMICs where 60 per cent of healthcare is financed outof-pocket, compared to 20 per cent out-ofpocket expenses in high-income countries (Coast et al., 2016; Quaife et al., 2014; Richards et al., 1999) . Local experts have advocated the need for an NCD-competent NHIS -a restructured system with an expanded remit to cover the comprehensive treatment needs of a growing number of Ghanaians living with cancers and other chronic conditions (de-Graft Aikins and Koram, 2017) . This will reduce the financial burden of care on individuals and families, as well as the associated psychosocial burdens.
Some of the participants in this study thought that breast cancer has spiritual causes. As a result, some of them sought alternative treatment which ended up delaying the time they started definitive treatment at KBTH. Some studies have also reported seeking of alternative treatment as a cause of delay in start of treatment (Freitas and Weller, 2015) . Other reasons given by participants for delay in start of treatment were spousal and family restrictions. Socio-cultural systems, as well as theories of disease and illness, especially in African settings, have been known to influence decision for seeking medical treatment especially in females (BeLue et al., 2009) . It has been reported that major decisions on women's health and wellbeing are usually taken by the husband or family member who determines whether it is appropriate to seek medical help based on their own beliefs, knowledge of the disease and financial status (Ohashi et al., 2014) . The narratives of the participants in this study suggest that some of the women delayed start of definitive treatment due to the advice given by their significant others (e.g. husbands, sisters and other valued family members).
Healthcare providers' and health systems' factors
The healthcare provider and health system delay were examined through the WHO health systems' building block framework. With regard to service delivery, this study showed that many of the patients did not have access to quality treatment due to the poor attitudes and corrupt practices of the healthcare workers. Associations have been made between Ghana's weak health system and recurring trends in corrupt health worker practices (de-Graft Aikins and Koram, 2017) . Corrupt practices entrenched inequitable access to breast cancer treatment at KBTH. Some of the participants were able to utilise the healthcare service faster than others because they attracted the favour of the healthcare workers either through bribery or leveraging their personal relationships with the healthcare workers. Other factors that hindered quality health service delivery included location of treatment facilities at different places within the hospital premises and long queues during treatment.
With respect to the health workforce, the participants mentioned shortage of healthcare workers as an impediment to receiving quality treatment. The number of breast cancer specialists at KBTH is very few to handle the influx of breast cancer patients and this contributed to delay in start of treatment. An effective way of addressing this may be using a task-shifting approach to train physicians in breast cancer care so as to increase the number of health professionals who can deliver this care (Adeloye and Grant, 2016) .
With respect to medical products and technology, the participants mentioned delay in biopsy results from Pathology Unit as a dominant cause of health system delay in start of treatment. This factor had been reported to be a major determinant of delay in start of definitive treatment at KBTH (Dedey et al., 2016) . In addition, intermittent breakdown of machines at the hospital due to power fluctuations and occasional delays in dispensing chemotherapy drugs are issues that are of concern to the country as a whole. With improvement in electricity supply to KBTH, subsidisation of cost of chemotherapy drugs and tax exemption on drugs, the above problems may be minimised (Vanderpuye and Yarney, 2014) .
With respect to recommendations on how to reduce delay in breast cancer treatment, the suggestions of the participants focused broadly on health service delivery, health workforce and financing. The other components of the health system -information and leadership/ governance -emerged as implicit concerns. For example, the lack of cancer education was implicated in low levels of awareness and understanding of breast cancer systems. This may be a product of poor investment in health information systems. The chronic problem with the operation of the Pathology Unit may also be a product of poor leadership and governance at the hospital.
The main limitation of this study was that the number of participants included in the FGDs was very limited. We could not gain access to more survey participants and we did not receive consent from all the 31 participants who we did reach. Despite this limitation, meaning saturation was reached on the majority of the discussion themes. As a result, the nuanced multi-level factors our participants outlined relating to causes of delay in start breast cancer treatment can inform larger-scale qualitative and quantitative studies and interventions in similar contexts.
Conclusion
This study showed that there were different causes and modalities of delay in start of definitive treatment for breast cancer and this included patients', healthcare workers' and health systems' factors. Reducing delays in breast cancer treatment at KBTH will require multi-level interventions which target these tripartite factors. Interventions should include the following: public education (and education of health workers) on causes and symptoms of breast cancer, including messages that deconstruct harmful cultural beliefs; psychosocial counselling before and during definitive treatment; and strengthening health systems in the areas of health service delivery (localisation of breast cancer treatment units at KBTH), health workforce (improving health professionals' attitudes, ethical conduct, welfare and diagnostic, and treatment timelines) and financing (advocating for an NCD-competent NHIS).
